SCHEMBL22508358

SCHEMBL22508358

CC/N=C(\CNCC)NCC

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.32
NOS1 P29475 1/20 0.31
ALDH1A1 P00352 1/20 0.31
CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20257873 0.77
SCHEMBL20457715 0.73
SCHEMBL5889479 0.70 NOS1 (0.34) NOS1
SCHEMBL13078397 0.68
Hydrochloric Acid SCHEMBL11623790 0.68 LDHA (0.33)
Hydrochloric Acid SCHEMBL11623786 0.68 LDHA (0.33)
SCHEMBL5889478 0.68 NOS1 (0.38) NOS1
SCHEMBL11159471 0.66 ALDH1A1 (0.38) NOS1ALDH1A1CYP3A4
SCHEMBL360164 0.64
SCHEMBL3072196 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020206000-A1 BIVALENT ANTAGONISTS OF INHIBITORS OF APOPTOSIS PROTEINS Hepagene Therapeutics (HK) Limited (CN) 2020-10-08 WO disclosed